NCT05627323 2026-01-29
CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
Chimeric Therapeutics
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT04214392 2025-10-06
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
City of Hope Medical Center
Phase 1 Active not recruiting
NCT00591058 2009-07-17
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1 Unknown
NCT00683761 2009-07-17
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1/2 Unknown
NCT00733798 2009-05-11
A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma
TransMolecular
Phase 1/2 Terminated
NCT00114309 2009-04-03
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
TransMolecular
Phase 2 Unknown
NCT00040573 2009-03-31
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
TransMolecular
Phase 1/2 Completed
NCT00379132 2009-03-31
131-I-TM-601 Study in Adults With Solid Tumors
TransMolecular
Phase 1 Completed